DHL boosts airfreight cold chain network
The Group has taken steps to strengthen its Life Sciences & Healthcare (LSH) logistics capabilities with an expanded dedicated Airfreight Cold Chain Network.
THE GLOBAL network is a core element of DHL’s €2 billion strategic investment in DHL Health Logistics gives customers full end-to-end visibility for highly sensitive healthcare products and supports the evolving logistics requirements of the world’s largest healthcare and pharmaceutical companies.
“Life sciences and healthcare companies expect cold chain solutions that are reliable, compliant, and transparent from end to end — and those expectations are rising fast,” says Oscar de Bok, CEO of DHL Global Forwarding, Freight. “At the same time, they’re looking for ways to simplify supply chains and reduce costs. Our expanded network brings together DHL Aviation’s global air connectivity, our GDP-compliant station network, and our major investments in modern, temperature-controlled facilities. The result is a more resilient, more efficient logistics backbone for customers who depend on flawless quality to deliver critical therapies to patients.”
The move reduces reliance on third-party carriers and commercial airlines, and adds capacity for temperature-sensitive pharmaceutical and medical shipments.
The network will first connect major DHL hubs, including Brussels (BRU) – Cincinnati (CVG), with additional routes in Europe, the Middle East, Asia, and Latin America to follow.
